位置:成果数据库 > 期刊 > 期刊详情页
整合素受体靶向显像诊断乳腺癌溶骨性转移
  • ISSN号:1001-9030
  • 期刊名称:中华实验外科杂志
  • 时间:2015.5.8
  • 页码:962-965
  • 分类:R73-37[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]南京医科大学附属南京医院核医学科,210006, [2]南京医科大学附属南京医院病理科,210006, [3]南京医科大学附属南京医院泌尿外科,210006, [4]南京医科大学附属第一医院核医学科
  • 相关基金:国家自然科学基金青年基金资助项目(81202032);江苏省自然科学基金资助项目(BK20130082);南京市医学科技发展资金项目(QRXll253)
  • 相关项目:IL-11R介导的分子探针对前列腺癌及骨转移抗癌作用及机理研究
中文摘要:

目的 探讨68镓-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-(精氨酸-甘氨酸-天冬氨酸)2(^68 Ga-DOTA-RGD2)正电子发射显像(microPET)/CT显像探测乳腺癌溶骨性转移的价值.方法 一步法制备^68 Ga-DOTA-RGD2,构建溶骨性骨病变模型(BP组)研究其生物学分布,左心室注射乳腺癌细胞(MDA-MB-231)构建乳腺癌骨转移模型(BM组),并行^68 Ga-DOTA-RGD2和18F-氟化钠(NaF) microPET/CT显像显像,由病理证实.结果 ^68 Ga-DOTA-RGD2体外稳定,血液、肺及肾脏中清除迅速,肝、脾摄取少且排泄快,甲状旁腺激素(PTH)注射侧颅骨^68Ga-DOTA-RGD2摄取(%ID/g)在尾静脉注射60 min达到峰值(5.14 ±0.65),显著高于BC组(2.06 ±0.35,t=7.81,P<0.05),MicroPET/CT显像示PTH注射侧与对侧顶骨放射性摄取比值^68Ga-DOTA-RGD2(4.57±0.97)明显高于^18F-NaF(1.20±0.33,t=10.17,P<0.05),BM组^68Ga-DOTA-RGD2显像可见颅骨、胸椎溶骨性转移灶及肺转移灶呈异常浓聚.结论 ^68 Ga-DOTA-RGD2整合素受体αvβ3靶向显像可早期发现溶骨性骨转移.

英文摘要:

Objective To investigate the value of integrin αvβ3 targeted micro positron emission tomography (microPET)/CT imaging with 68 Ca-1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid-arginine-glycine-aspartate peptide dimer (^68 Ga-DOTA-RGD2) as radiotracer for the detection of breast cancer osteolytic bone metastases.Methods 68 Ga-DOTA-RGD2 was prepared via one-step method at 100 ℃ for 15 min.Animal model with parathyroid hormone (PTH)-induced osteolysis in the calvarium was established and served as PTH group (BP).Biodistribution study of ^68 Ga-DOTA-RGD2 was carried out in BP.Integrin receptor block study was done with pre-injection of high dose of DOTA-RGD2.^68Ga-DOTA-RGD2 and ^18F-NaF micmPET/CT imaging were perfromed respectively.Breast cancer osteolyic bone metastases was established via intrcardial injection of breast cancer cells.^68 Ga-DOTA-RGD2 microPET/CT imaging were perfromed for the detection of breast cancer osetolytic bone metastases.Animals were sarcrificed and bone lesions were harvested for pathological examination.Results 68 Ga-DOTA-RGD2 was stable in vitro and its radiopurity was as high as (96.4 ± 2.1) % 3 h after its preparation.Its blood elimination was fast while its uptake by the liver and kidneys were relativelylow.It was discharged soon after its intravenous injection.In the BP group,regional uptake of ^68 Ga-DOTA-RGD2 in osteolytic lesion of calvarium (% ID/g) reached peak (5.14 ±0.65) 60 min after tail vein injection.It was significantly more than that in BC group (2.06 ±0.35,t =7.81,P 〈0.05).Bone radiotracer uptake ratio of osteolytic lesion to normal calvrium (O/N) was compared based microPET/CT imaging.Bone O/N of 68Ga-DOTA-RGD2 was (6.10 ± 0.97),significantly greater than that of ^18F-NaF (1.20 ±0.33,t =10.17,P 〈0.05).^68Ga-DOTA-RGD2 microPET/CT imaging was able to demonstrate the ostelytic bone metastasis in calvarium,thoracic vertebrae and lung metastasis.They were confirmed by pathology results.Conclusion

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华实验外科杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中华医学会
  • 主编:
  • 地址:武汉市武昌区东湖路165号
  • 邮编:430064
  • 邮箱:cjes@cma.org.cn
  • 电话:027-87893475
  • 国际标准刊号:ISSN:1001-9030
  • 国内统一刊号:ISSN:42-1213/R
  • 邮发代号:38-85
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:34996